Safety and Efficacy of Intravenous Administration of SHED-CM for ALS
Safety and Efficacy of Intravenous Administration of SHED-CM for ALS
Active, not recruiting · NCT06889857 · Registry updated 2025-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Intravenous Administration of SHED-CM for ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Early phase 1 | 2025-09-15 | NCT06889857 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hitonowa Medical | 1 |
| U-Factor Co.,Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hitonowa Medical | Chiyoda City | Japan | 1 |